Lisa Wisniewski
InvestorChief Scientific Officer at Global BioAccess Fund
About
Lisa Wisniewski is Chief Scientific Officer at Global BioAccess Fund and a drug development executive with over 25 years of experience across therapeutic areas including oncology, anti-infectives, and vaccines. A licensed investment banker and Managing Director at RM Global Partners, she advises clients on asset development, private placements, and out-licensing, and she serves as CSO for the RMG Healthcare Fund. Her prior roles include Vice President of R&D Operations at Ikaria and Executive Director, Global Program Leader at Celgene, along with earlier positions at Novartis and Chiron.
Invests in
Biotech
Colleagues at Global BioAccess Fund
Bruce Roberts
Managing Partner at Global BioAccess Fund
Dave Praharaj
Senior Associate at Global BioAccess Fund
Dave Praharaj, MD
Senior Associate at Global BioAccess Fund
Kevin Cyr
Research Associate at Global BioAccess Fund
Kevin Cyr, MD
Research Associate at Global BioAccess Fund
Lisa Wisniewski, PhD
Managing Director at Global BioAccess Fund
Michael Krepps
Venture Partner at Global BioAccess Fund
Sonia Gulati
Principal at Global BioAccess Fund